<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="other"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Indian J Ophthalmol</journal-id><journal-id journal-id-type="publisher-id">Indian Journal of Ophthalmology</journal-id><journal-title-group><journal-title>Indian Journal of Ophthalmology</journal-title></journal-title-group><issn pub-type="ppub">0301-4738</issn><issn pub-type="epub">1998-3689</issn><publisher><publisher-name>Medknow Publications</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">18292630</article-id><article-id pub-id-type="pmc">2636093</article-id><article-id pub-id-type="publisher-id">IndianJOphthalmol_2008_56_2_153_39124</article-id><article-categories><subj-group subj-group-type="heading"><subject>Brief Communication</subject></subj-group></article-categories><title-group><article-title>Ocular adnexal lymphoma in the Northeast Indian population</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Das</surname><given-names>Dipankar</given-names></name><degrees>MS</degrees></contrib><contrib contrib-type="author"><name><surname>Deka</surname><given-names>Panna</given-names></name><degrees>MD</degrees></contrib><contrib contrib-type="author"><name><surname>Bhattacharjee</surname><given-names>Kasturi</given-names></name><degrees>MS, FRCS</degrees></contrib><contrib contrib-type="author"><name><surname>Das</surname><given-names>Jayanta Kumar</given-names></name><degrees>DNB</degrees></contrib><contrib contrib-type="author"><name><surname>Kuri</surname><given-names>Ganesh</given-names></name><degrees>MS</degrees></contrib><contrib contrib-type="author"><name><surname>Deka</surname><given-names>Akshay Chandra</given-names></name><degrees>MSMLT</degrees></contrib><contrib contrib-type="author"><name><surname>Bhattacharjee</surname><given-names>Harsha</given-names></name><degrees>MS</degrees></contrib></contrib-group><aff>Sri Sankardeva Nethralaya, Beltola, Guwahati - 781 028, Assam, India</aff><author-notes><corresp id="cor1">Correspondence to Dr Dipankar Das, Sri Sankaradeva Nethralaya, Beltola,Guwahati - 781 028, Assam, India. Email: <email>dr_dasdipankar@yahoo.com</email></corresp></author-notes><pub-date pub-type="ppub"><season>Mar-Apr</season><year>2008</year></pub-date><volume>56</volume><issue>2</issue><fpage>153</fpage><lpage>155</lpage><history><date date-type="received"><day>04</day><month>8</month><year>2006</year></date><date date-type="accepted"><day>29</day><month>5</month><year>2007</year></date></history><permissions><copyright-statement>Copyright: &#x000a9; Indian Journal of Ophthalmology</copyright-statement><copyright-year>2008</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open-access		article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits		unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>We present the clinical profile of biopsy andimmunohistochemistry-proven ocular adnexal lymphomas inthe Northeast Indian population. Nineteen patients betweenOctober 2004 and June 2006 with ocular adnexal lymphoma wereanalyzed retrospectively. Histopathological classification wasdone according to international working formulation. Twelvepatients were male and seven were female. All were diagnosedas non-Hodgkin&#x02032;s lymphoma and the majority were B cell type(89%). Most of the cases (42%)were treated with radiotherapyfollowed by chemotherapy.</p></abstract><kwd-group><kwd>Histopathology</kwd><kwd>immunohistochemistry</kwd><kwd>non-Hodgkin&#x02032;s lymphoma</kwd><kwd>ocular adnexa</kwd></kwd-group></article-meta></front><body><p>Lymphoid tumors are amongst the common neoplasms ofocular adnexa encountered by ophthalmologists. Lymphomasare malignant neoplasms characterized by propagationof cells natural to the lymphoid tissue.<xref ref-type="bibr" rid="ref1">1</xref> Ocular adnexallymphoid tumors may involve the eyelids, conjunctiva, orbitalconnective tissue or lacrimal gland. Lymphoma is broadlyclassified into main two types - A) Hodgkin&#x02032;s lymphoma andB) Non-Hodgkin&#x02032;s lymphoma (NHL). The onset is generallyin the sixth and seventh decades of life and it is uncommonin children.<xref ref-type="bibr" rid="ref1">1</xref>,<xref ref-type="bibr" rid="ref2">2</xref> The detailed descriptions of ocularadnexal lymphoma in Northeast India have not been previouslyreported. Few studies on lymphoma in India<xref ref-type="bibr" rid="ref3">3</xref>,<xref ref-type="bibr" rid="ref4">4</xref> arereported in the literature. We present this retrospective hospital-basedstudy on ocular adnexal lymphomas from the Northeasternpart of India.</p><sec sec-type="materials|methods"><title>Materials and Methods</title><p>Case records from the Ocular Pathology Laboratory of19 patients who presented between October 2004 and June 2006were retrospectively analyzed. The modes of presentation werestudied. All the cases were biopsy and immunohistochemicallyproven. Following a diagnosis of lymphoma, all patients wereevaluated by a medical oncologist for systemic involvement. Adetailed history followed by Snellen&#x02032;s visual acuity, slit-lampbiomicroscopy, applanation tonometry, fundus evaluation byindirect ophthalmoscopy and detailed proptosis evaluationwas done for all patients. B scans, ultrasound and computedtomography (CT) scan was done in all cases.</p></sec><sec><title>Results</title><p>Nineteen patients were analyzed retrospectively, 12 patients(63%) were male and seven (37%) were female. The ageranged from 22 years to 85 years with mean age of 59.36 years[<xref ref-type="table" rid="T1">Table 1</xref>]. Nine patients (47%) presented with proptosisand five patients (26%) presented with an upper lid mass;three (15%) as conjunctival mass and two (11%) as lacrimalgland swelling [<xref ref-type="table" rid="T2">Table 2</xref>]. There was no past history of orbitalinflammatory disease in our series. All patients underwentincision biopsy from respective site in most of the cases andconfirmed histopathologically and with immunohistochemistry (IHC).Histopathological classification was done accordingto international working formulation. Most of the tumorsmorphologically consisted of heterogeneous population ofB-lymphocytes, cells with relatively large amounts of pale orbasophilic cytoplasm that have monocytoid appearance andscattered immunoblast and centroblast-like cells. A proportionof cases showed plasma cell differentiation. Moreover, thetumor cells had a round to oval nucleus that appeared vesicular.Some of the nuclei were cleaved. All patients were havingNHL. B-cell lymphomas (CD20, IHC) were seen in 17 cases(89%) [<xref ref-type="fig" rid="F1">Fig. 1</xref>], T-cell lymphoma (CD3, IHC) in one case (5%)[<xref ref-type="fig" rid="F2">Fig. 2</xref> and <xref ref-type="fig" rid="F3">Fig. 3</xref>] and lymphoepithelial lymphoma in onecase (5%) [<xref ref-type="fig" rid="F4">Fig. 4</xref>]. Immunophenotypic analysis has shown thatmost of the ocular adnexal lymphoid tumors are monoclonalproliferation of B-lymphocytes consistent with NHL.Histologically, orbital lymphomas were low to intermediatein grade with predominance of the low-grade variety. Therange of follow-up was from three months to two years. Eightpatients (42%) had local radiotherapy in doses ranging from25Gy to 46Gy, two (11%) had CHOP (cyclophosphomide,doxorubicin, vincristine and prednisolone) chemotherapyalone and one had combination with local radiation (28-30Gy)and chemotherapy COP (cyclophosphomide, vincristine andprednisolone). None of the patients had systemic involvementand local recurrence.</p></sec><sec><title>Discussion</title><p>Ocular adnexal lymphoid lesions show characteristic clinicalfeatures in most of the patients. They are most commonlyseen in the sixth to seventh decade of life with a slightfemale preponderance. But the present study showed malepredominance (63%) which is comparable with other studiesfrom India.<xref ref-type="bibr" rid="ref3">3</xref>,<xref ref-type="bibr" rid="ref4">4</xref> The most common site of involvement oflymphoid tumor is the superior orbit behind the orbital septumand 30 to 40% arise from the lacrimal gland.<xref ref-type="bibr" rid="ref5">5</xref> In our study 10%of the cases presented with lacrimal gland involvement. Thelesion in this location results in proptosis with downwarddisplacement of globe. Eleven patients (58%) presented with amass in the superior orbit, either having lid mass or proptosis.L26 clone of B-cell marker CD20 and the UCHL-1 clone of T-cellmarkers CD45RO or CD 3 were used for immunohistochemistryanalysis.</p><p>Most of the tumors were B-cell origin (89%) followed by T-cell origin (5%) and lymphoepitheloid lymphoma (5%) [<xref ref-type="fig" rid="F4">Fig. 4</xref>].Jakobiec has stressed that more than 60% of ocular adnexallymphoid infiltrates are composed of B-cell lymphomas.<xref ref-type="bibr" rid="ref6">6</xref> T-celllymphomas are rare in the ocular adnexa and can be suspectedon clinical and histopathological grounds.<xref ref-type="bibr" rid="ref6">6</xref> A tumor composedof small lymphocytes that are CD5+ and also express CD23is probably small lymphocytic lymphoma (SLL), not a MALTlymphoma. CD5+ Mantle cell lymphoma is distinguishedfrom SLL by positive staining for cyclin D1 and negativefor CD23.<xref ref-type="bibr" rid="ref7">7</xref> None of the patients had Hodgkin&#x02032;s lymphoma,which by itself a rarity in the orbit.<xref ref-type="bibr" rid="ref2">2</xref> Primary cases requiredsurgical intervention consisting of excision and debulking.Most of the patients required radiation with careful ocularshielding and some required chemotherapy based on workingclassification of NHL. None of the patients had a recurrenceof the tumor or any systemic involvement. One of the mostimportant prognostic factors was the extent of the diseasediscovered after thorough clinical staging.<xref ref-type="bibr" rid="ref8">8</xref> Long follow-upis required to comment on final outcome. All patients withocular adnexal lymphoid tumor had a thorough systemicevaluation by an oncologist which included a complete bloodcount, bone marrow biopsy and ultrasonogram and CT scanof the body and abdomen.<xref ref-type="bibr" rid="ref7">7</xref>,<xref ref-type="bibr" rid="ref9">9</xref>,<xref ref-type="bibr" rid="ref10">10</xref> Patients were re-evaluated at three months interval.</p></sec><sec><title>Conclusion</title><p>Malignant ocular adnexal lymphomas are common neoplasm inthe Northeast Indian population. In a 20-month period we saw19 cases of NHL in our series. NHL (B-cell type) is the prime typeencountered in the assortment of ocular adnexal lesions and theorbit is the foremost extranodal site of association. While thenumber of patients presented here is small, the clinical inferenceis that histological recognition of B-cell NHL in this part is asignificant observation.<xref ref-type="bibr" rid="ref4">4</xref> Males are on the whole affected morethan females. Superior orbit is the commonest site of the lesion.Correct histological diagnosis with immunohistochemistryensures appropriate treatment.</p></sec></body><back><ref-list><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ellis</surname><given-names>JH</given-names></name><name><surname>Banks</surname><given-names>PM</given-names></name><name><surname>Campbell</surname><given-names>RJ</given-names></name><name><surname>Lieseganj</surname><given-names>TJ</given-names></name></person-group><article-title>Lymphoid tumours of the ocular adnexa: Clinical correlation with the working classification and immunoperoxidase stainingof paraffin section</article-title><source>Ophthalmology</source><year>1985</year><volume>92</volume><fpage>1311</fpage><lpage>24</lpage><pub-id pub-id-type="pmid">3906488</pub-id></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McNully</surname><given-names>L</given-names></name><name><surname>Jacobiec</surname><given-names>FA</given-names></name><name><surname>Knowles</surname><given-names>DM</given-names></name></person-group><article-title>Clinical, Morphologic, Immunophenotypic and Molecular genetic analysis of bilateral ocular adnexal lymphoid neoplasm in17 patients</article-title><source>Am J Ophthalmol</source><year>1987</year><volume>103</volume><fpage>555</fpage><lpage>68</lpage><pub-id pub-id-type="pmid">3494404</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramani</surname><given-names>A</given-names></name><name><surname>Kumar</surname><given-names>KA</given-names></name><name><surname>Rao</surname><given-names>KK</given-names></name><name><surname>Vidyasagar</surname><given-names>MS</given-names></name><name><surname>Kundaje</surname><given-names>GN</given-names></name></person-group><article-title>Clinico pathological profile of lymphoma in south India: A prospective rural referral hospital study of 103]cases</article-title><source>J Assoc Physician India</source><year>1991</year><volume>39</volume><fpage>322</fpage><lpage>5</lpage></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aziz</surname><given-names>SA</given-names></name><name><surname>Agrawal</surname><given-names>SS</given-names></name><name><surname>Agarwal</surname><given-names>SS</given-names></name></person-group><article-title>Clinicopathological profile of lymphomas in India</article-title><source>J Assoc Physicians India</source><year>1992</year><volume>40</volume><fpage>356</fpage><pub-id pub-id-type="pmid">1484016</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knowles</surname><given-names>DM</given-names></name><name><surname>Jakobiec</surname><given-names>FA</given-names></name><name><surname>McNally</surname><given-names>L</given-names></name><name><surname>Burke</surname><given-names>JS</given-names></name></person-group><article-title>Lymphoid hyperplasia and malignant lymphoma occurring in ocular adnexa (orbit, conjunctiva and eyelids): A prospectivemultiparametric analysis of 108 cases during 1977 to 1987</article-title><source>Hum Pathol</source><year>1990</year><volume>21</volume><fpage>959</fpage><lpage>73</lpage><pub-id pub-id-type="pmid">2394438</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hornblass</surname><given-names>A</given-names></name><name><surname>Jakobiec</surname><given-names>FA</given-names></name><name><surname>Reifler</surname><given-names>DM</given-names></name><name><surname>Mines</surname><given-names>J</given-names></name></person-group><article-title>Orbital lymphoid tumours located predominantly within extraocular muscles</article-title><source>Ophthalmology</source><year>1987</year><volume>94</volume><fpage>688</fpage><lpage>97</lpage><pub-id pub-id-type="pmid">3627718</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Auw Haedrich</surname><given-names>C</given-names></name><name><surname>Coupland</surname><given-names>SE</given-names></name><name><surname>Kapp</surname><given-names>A</given-names></name><name><surname>Schmitt-Graff</surname><given-names>A</given-names></name><name><surname>Buchen</surname><given-names>R</given-names></name><name><surname>Witschel</surname><given-names>H</given-names></name></person-group><article-title>Long term outcome of ocular adnexal lymphoma subtyped according to REAL classification: Revised European and Americanlymphoma</article-title><source>Br J Ophthalmol</source><year>2001</year><volume>85</volume><fpage>63</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">11133714</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coupland</surname><given-names>SE</given-names></name><name><surname>Hummel</surname><given-names>M</given-names></name><name><surname>Stein</surname><given-names>H</given-names></name></person-group><article-title>Ocular adnexal lymphoma:five case presentation and a review of literature</article-title><source>Surv Ophthalmol</source><year>2002</year><volume>47</volume><fpage>470</fpage><lpage>90</lpage><pub-id pub-id-type="pmid">12431695</pub-id></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>White</surname><given-names>WL</given-names></name><name><surname>Ferry</surname><given-names>JA</given-names></name><name><surname>Harris</surname><given-names>NL</given-names></name><name><surname>Grove</surname><given-names>AS</given-names><suffix>Jr</suffix></name></person-group><article-title>Ocular adnexal lymphoma: A clinicopathologic study with identification of mucosa-associated lymphoid tissuetype</article-title><source>Ophthalmology</source><year>1995</year><volume>102</volume><fpage>1994</fpage><lpage>2006</lpage><pub-id pub-id-type="pmid">9098307</pub-id></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jenkins</surname><given-names>C</given-names></name><name><surname>Rose</surname><given-names>GE</given-names></name><name><surname>Bunce</surname><given-names>C</given-names></name><name><surname>Cree</surname><given-names>I</given-names></name><name><surname>Norton</surname><given-names>A</given-names></name><name><surname>Plowman</surname><given-names>PN</given-names></name><etal/></person-group><article-title>Clinical features associated with survival of patients with lymphoma of ocular adnexa</article-title><source>Eye</source><year>2003</year><volume>17</volume><fpage>809</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">14528242</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" position="float"><label>Figure 1</label><caption><p>Lymphoid proliferation of monoclonal B-cell lymphoma (H/E, &#x000d7;40)</p></caption><alt-text>Figure 1</alt-text><graphic xlink:href="IndianJOphthalmol-56-153-g003"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><p>T-cell lymphoma which was confirmed by IHC (H/E, &#x000d7;40)</p></caption><alt-text>Figure 2</alt-text><graphic xlink:href="IndianJOphthalmol-56-153-g004"/></fig><fig id="F3" position="float"><label>Figure 3</label><caption><p>Corresponding IHC for T-cell marker (Immunostain with CD45RO, &#x000d7;40)</p></caption><alt-text>Figure 3</alt-text><graphic xlink:href="IndianJOphthalmol-56-153-g005"/></fig><fig id="F4" position="float"><label>Figure 4</label><caption><p>Lymphoepithelial lymphoma (H/E, &#x000d7;40)</p></caption><alt-text>Figure 4</alt-text><graphic xlink:href="IndianJOphthalmol-56-153-g006"/></fig><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Profile of Non-Hodgkin's lymphoma</p></caption><alt-text>Table 1</alt-text><graphic xlink:href="IndianJOphthalmol-56-153-g001"/></table-wrap><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Various presentations of Non-Hodgkin's lymphomas with percentage</p></caption><alt-text>Table 2</alt-text><graphic xlink:href="IndianJOphthalmol-56-153-g002"/></table-wrap></floats-group></article>